Biovail Corporation And Athpharma Limited To End Pact On Heart Drugs

TORONTO, July 24 (Reuters) - Biovail Corp. (BVF.TO: Quote, Profile, Research) (BVF.N: Quote, Profile, Research) and Athpharma Ltd. said on Monday they will terminate a joint development deal related to four development-stage cardiovascular products.